UK ministers attempt to provide certainty on EMA relations post-Brexit

After a year of uncertainty, a letter written by two senior government ministers has finally sought to clear up what the UK’s relationship with the European Medicines Agency (EMA) might look like after Brexit.

Whether the letter, sent to The Financial Times by Health Secretary Jeremy Hunt and Business Secretary Greg Clark, does clear anything up, is open to interpretation. But it certainly shows a preference for the UK to have a close working relationship with the EMA.

They state that this future cooperation is important “in the interests of public health and safety” and highlight how the EMA, with the UK as a part of it, has had a positive impact in areas such as developing products for rare diseases.